Abstract
Summary
LPI (LP Information)' newest research report, the “Network Point-of-Care Glucose Testing Device Industry Forecast” looks at past sales and reviews total world Network Point-of-Care Glucose Testing Device sales in 2022, providing a comprehensive analysis by region and market sector of projected Network Point-of-Care Glucose Testing Device sales for 2023 through 2029. With Network Point-of-Care Glucose Testing Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Network Point-of-Care Glucose Testing Device industry.
This Insight Report provides a comprehensive analysis of the global Network Point-of-Care Glucose Testing Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Network Point-of-Care Glucose Testing Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Network Point-of-Care Glucose Testing Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Network Point-of-Care Glucose Testing Device and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Network Point-of-Care Glucose Testing Device.
The global Network Point-of-Care Glucose Testing Device market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Network Point-of-Care Glucose Testing Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Network Point-of-Care Glucose Testing Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Network Point-of-Care Glucose Testing Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Network Point-of-Care Glucose Testing Device players cover Roche Holding AG, Ascensia Diabetes Care Holdings AG, Nova Biomedical, LifeScan, Inc., Danaher Corporation, Prodigy Diabetes Care, Johnson & Johnson, Nipro and ACON Laboratories, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Network Point-of-Care Glucose Testing Device market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
0.5uL/0.6uL
1uL
1.5uL
Others
Segmentation by application
Hospital
Clinic
Household
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche Holding AG
Ascensia Diabetes Care Holdings AG
Nova Biomedical
LifeScan, Inc.
Danaher Corporation
Prodigy Diabetes Care
Johnson & Johnson
Nipro
ACON Laboratories, Inc.
Trividia Health, Inc.
Panasonic Healthcare Holdings
EKF Diagnostics
Omron
B. Braun
77 Elektronika
AgaMatrix
Terumo
Key Questions Addressed in this Report
What is the 10-year outlook for the global Network Point-of-Care Glucose Testing Device market?
What factors are driving Network Point-of-Care Glucose Testing Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Network Point-of-Care Glucose Testing Device market opportunities vary by end market size?
How does Network Point-of-Care Glucose Testing Device break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
This Insight Report provides a comprehensive analysis of the global Network Point-of-Care Glucose Testing Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Network Point-of-Care Glucose Testing Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Network Point-of-Care Glucose Testing Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Network Point-of-Care Glucose Testing Device and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Network Point-of-Care Glucose Testing Device.
The global Network Point-of-Care Glucose Testing Device market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Network Point-of-Care Glucose Testing Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Network Point-of-Care Glucose Testing Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Network Point-of-Care Glucose Testing Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Network Point-of-Care Glucose Testing Device players cover Roche Holding AG, Ascensia Diabetes Care Holdings AG, Nova Biomedical, LifeScan, Inc., Danaher Corporation, Prodigy Diabetes Care, Johnson & Johnson, Nipro and ACON Laboratories, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Network Point-of-Care Glucose Testing Device market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
0.5uL/0.6uL
1uL
1.5uL
Others
Segmentation by application
Hospital
Clinic
Household
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche Holding AG
Ascensia Diabetes Care Holdings AG
Nova Biomedical
LifeScan, Inc.
Danaher Corporation
Prodigy Diabetes Care
Johnson & Johnson
Nipro
ACON Laboratories, Inc.
Trividia Health, Inc.
Panasonic Healthcare Holdings
EKF Diagnostics
Omron
B. Braun
77 Elektronika
AgaMatrix
Terumo
Key Questions Addressed in this Report
What is the 10-year outlook for the global Network Point-of-Care Glucose Testing Device market?
What factors are driving Network Point-of-Care Glucose Testing Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Network Point-of-Care Glucose Testing Device market opportunities vary by end market size?
How does Network Point-of-Care Glucose Testing Device break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Network Point-of-Care Glucose Testing Device Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Network Point-of-Care Glucose Testing Device by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Network Point-of-Care Glucose Testing Device by Country/Region, 2018, 2022 & 2029
2.2 Network Point-of-Care Glucose Testing Device Segment by Type
2.2.1 0.5uL/0.6uL
2.2.2 1uL
2.2.3 1.5uL
2.2.4 Others
2.3 Network Point-of-Care Glucose Testing Device Sales by Type
2.3.1 Global Network Point-of-Care Glucose Testing Device Sales Market Share by Type (2018-2023)
2.3.2 Global Network Point-of-Care Glucose Testing Device Revenue and Market Share by Type (2018-2023)
2.3.3 Global Network Point-of-Care Glucose Testing Device Sale Price by Type (2018-2023)
2.4 Network Point-of-Care Glucose Testing Device Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Household
2.5 Network Point-of-Care Glucose Testing Device Sales by Application
2.5.1 Global Network Point-of-Care Glucose Testing Device Sale Market Share by Application (2018-2023)
2.5.2 Global Network Point-of-Care Glucose Testing Device Revenue and Market Share by Application (2018-2023)
2.5.3 Global Network Point-of-Care Glucose Testing Device Sale Price by Application (2018-2023)
3 Global Network Point-of-Care Glucose Testing Device by Company
3.1 Global Network Point-of-Care Glucose Testing Device Breakdown Data by Company
3.1.1 Global Network Point-of-Care Glucose Testing Device Annual Sales by Company (2018-2023)
3.1.2 Global Network Point-of-Care Glucose Testing Device Sales Market Share by Company (2018-2023)
3.2 Global Network Point-of-Care Glucose Testing Device Annual Revenue by Company (2018-2023)
3.2.1 Global Network Point-of-Care Glucose Testing Device Revenue by Company (2018-2023)
3.2.2 Global Network Point-of-Care Glucose Testing Device Revenue Market Share by Company (2018-2023)
3.3 Global Network Point-of-Care Glucose Testing Device Sale Price by Company
3.4 Key Manufacturers Network Point-of-Care Glucose Testing Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Network Point-of-Care Glucose Testing Device Product Location Distribution
3.4.2 Players Network Point-of-Care Glucose Testing Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Network Point-of-Care Glucose Testing Device by Geographic Region
4.1 World Historic Network Point-of-Care Glucose Testing Device Market Size by Geographic Region (2018-2023)
4.1.1 Global Network Point-of-Care Glucose Testing Device Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Network Point-of-Care Glucose Testing Device Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Network Point-of-Care Glucose Testing Device Market Size by Country/Region (2018-2023)
4.2.1 Global Network Point-of-Care Glucose Testing Device Annual Sales by Country/Region (2018-2023)
4.2.2 Global Network Point-of-Care Glucose Testing Device Annual Revenue by Country/Region (2018-2023)
4.3 Americas Network Point-of-Care Glucose Testing Device Sales Growth
4.4 APAC Network Point-of-Care Glucose Testing Device Sales Growth
4.5 Europe Network Point-of-Care Glucose Testing Device Sales Growth
4.6 Middle East & Africa Network Point-of-Care Glucose Testing Device Sales Growth
5 Americas
5.1 Americas Network Point-of-Care Glucose Testing Device Sales by Country
5.1.1 Americas Network Point-of-Care Glucose Testing Device Sales by Country (2018-2023)
5.1.2 Americas Network Point-of-Care Glucose Testing Device Revenue by Country (2018-2023)
5.2 Americas Network Point-of-Care Glucose Testing Device Sales by Type
5.3 Americas Network Point-of-Care Glucose Testing Device Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Network Point-of-Care Glucose Testing Device Sales by Region
6.1.1 APAC Network Point-of-Care Glucose Testing Device Sales by Region (2018-2023)
6.1.2 APAC Network Point-of-Care Glucose Testing Device Revenue by Region (2018-2023)
6.2 APAC Network Point-of-Care Glucose Testing Device Sales by Type
6.3 APAC Network Point-of-Care Glucose Testing Device Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Network Point-of-Care Glucose Testing Device by Country
7.1.1 Europe Network Point-of-Care Glucose Testing Device Sales by Country (2018-2023)
7.1.2 Europe Network Point-of-Care Glucose Testing Device Revenue by Country (2018-2023)
7.2 Europe Network Point-of-Care Glucose Testing Device Sales by Type
7.3 Europe Network Point-of-Care Glucose Testing Device Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Network Point-of-Care Glucose Testing Device by Country
8.1.1 Middle East & Africa Network Point-of-Care Glucose Testing Device Sales by Country (2018-2023)
8.1.2 Middle East & Africa Network Point-of-Care Glucose Testing Device Revenue by Country (2018-2023)
8.2 Middle East & Africa Network Point-of-Care Glucose Testing Device Sales by Type
8.3 Middle East & Africa Network Point-of-Care Glucose Testing Device Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Network Point-of-Care Glucose Testing Device
10.3 Manufacturing Process Analysis of Network Point-of-Care Glucose Testing Device
10.4 Industry Chain Structure of Network Point-of-Care Glucose Testing Device
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Network Point-of-Care Glucose Testing Device Distributors
11.3 Network Point-of-Care Glucose Testing Device Customer
12 World Forecast Review for Network Point-of-Care Glucose Testing Device by Geographic Region
12.1 Global Network Point-of-Care Glucose Testing Device Market Size Forecast by Region
12.1.1 Global Network Point-of-Care Glucose Testing Device Forecast by Region (2024-2029)
12.1.2 Global Network Point-of-Care Glucose Testing Device Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Network Point-of-Care Glucose Testing Device Forecast by Type
12.7 Global Network Point-of-Care Glucose Testing Device Forecast by Application
13 Key Players Analysis
13.1 Roche Holding AG
13.1.1 Roche Holding AG Company Information
13.1.2 Roche Holding AG Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications
13.1.3 Roche Holding AG Network Point-of-Care Glucose Testing Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Roche Holding AG Main Business Overview
13.1.5 Roche Holding AG Latest Developments
13.2 Ascensia Diabetes Care Holdings AG
13.2.1 Ascensia Diabetes Care Holdings AG Company Information
13.2.2 Ascensia Diabetes Care Holdings AG Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications
13.2.3 Ascensia Diabetes Care Holdings AG Network Point-of-Care Glucose Testing Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Ascensia Diabetes Care Holdings AG Main Business Overview
13.2.5 Ascensia Diabetes Care Holdings AG Latest Developments
13.3 Nova Biomedical
13.3.1 Nova Biomedical Company Information
13.3.2 Nova Biomedical Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications
13.3.3 Nova Biomedical Network Point-of-Care Glucose Testing Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Nova Biomedical Main Business Overview
13.3.5 Nova Biomedical Latest Developments
13.4 LifeScan, Inc.
13.4.1 LifeScan, Inc. Company Information
13.4.2 LifeScan, Inc. Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications
13.4.3 LifeScan, Inc. Network Point-of-Care Glucose Testing Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 LifeScan, Inc. Main Business Overview
13.4.5 LifeScan, Inc. Latest Developments
13.5 Danaher Corporation
13.5.1 Danaher Corporation Company Information
13.5.2 Danaher Corporation Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications
13.5.3 Danaher Corporation Network Point-of-Care Glucose Testing Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Danaher Corporation Main Business Overview
13.5.5 Danaher Corporation Latest Developments
13.6 Prodigy Diabetes Care
13.6.1 Prodigy Diabetes Care Company Information
13.6.2 Prodigy Diabetes Care Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications
13.6.3 Prodigy Diabetes Care Network Point-of-Care Glucose Testing Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Prodigy Diabetes Care Main Business Overview
13.6.5 Prodigy Diabetes Care Latest Developments
13.7 Johnson & Johnson
13.7.1 Johnson & Johnson Company Information
13.7.2 Johnson & Johnson Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications
13.7.3 Johnson & Johnson Network Point-of-Care Glucose Testing Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Johnson & Johnson Main Business Overview
13.7.5 Johnson & Johnson Latest Developments
13.8 Nipro
13.8.1 Nipro Company Information
13.8.2 Nipro Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications
13.8.3 Nipro Network Point-of-Care Glucose Testing Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Nipro Main Business Overview
13.8.5 Nipro Latest Developments
13.9 ACON Laboratories, Inc.
13.9.1 ACON Laboratories, Inc. Company Information
13.9.2 ACON Laboratories, Inc. Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications
13.9.3 ACON Laboratories, Inc. Network Point-of-Care Glucose Testing Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 ACON Laboratories, Inc. Main Business Overview
13.9.5 ACON Laboratories, Inc. Latest Developments
13.10 Trividia Health, Inc.
13.10.1 Trividia Health, Inc. Company Information
13.10.2 Trividia Health, Inc. Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications
13.10.3 Trividia Health, Inc. Network Point-of-Care Glucose Testing Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Trividia Health, Inc. Main Business Overview
13.10.5 Trividia Health, Inc. Latest Developments
13.11 Panasonic Healthcare Holdings
13.11.1 Panasonic Healthcare Holdings Company Information
13.11.2 Panasonic Healthcare Holdings Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications
13.11.3 Panasonic Healthcare Holdings Network Point-of-Care Glucose Testing Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Panasonic Healthcare Holdings Main Business Overview
13.11.5 Panasonic Healthcare Holdings Latest Developments
13.12 EKF Diagnostics
13.12.1 EKF Diagnostics Company Information
13.12.2 EKF Diagnostics Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications
13.12.3 EKF Diagnostics Network Point-of-Care Glucose Testing Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 EKF Diagnostics Main Business Overview
13.12.5 EKF Diagnostics Latest Developments
13.13 Omron
13.13.1 Omron Company Information
13.13.2 Omron Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications
13.13.3 Omron Network Point-of-Care Glucose Testing Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Omron Main Business Overview
13.13.5 Omron Latest Developments
13.14 B. Braun
13.14.1 B. Braun Company Information
13.14.2 B. Braun Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications
13.14.3 B. Braun Network Point-of-Care Glucose Testing Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 B. Braun Main Business Overview
13.14.5 B. Braun Latest Developments
13.15 77 Elektronika
13.15.1 77 Elektronika Company Information
13.15.2 77 Elektronika Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications
13.15.3 77 Elektronika Network Point-of-Care Glucose Testing Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 77 Elektronika Main Business Overview
13.15.5 77 Elektronika Latest Developments
13.16 AgaMatrix
13.16.1 AgaMatrix Company Information
13.16.2 AgaMatrix Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications
13.16.3 AgaMatrix Network Point-of-Care Glucose Testing Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 AgaMatrix Main Business Overview
13.16.5 AgaMatrix Latest Developments
13.17 Terumo
13.17.1 Terumo Company Information
13.17.2 Terumo Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications
13.17.3 Terumo Network Point-of-Care Glucose Testing Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Terumo Main Business Overview
13.17.5 Terumo Latest Developments
14 Research Findings and Conclusion